NAICS Code 541714-21 - Laboratories-Biochemical

Marketing Level - NAICS 8-Digit

Business Lists and Databases Available for Marketing and Research

Total Verified Companies: 27
Contact Emails: 85
Company Websites: 24
Phone Numbers: 27
Business Addresses: 27
Companies with Email: 16
Reach new customers, connect with decision makers, and grow your business.
Pricing from $0.05 to $0.25 per lead

Business List Pricing Tiers

Quantity of Records Price Per Record Estimated Total (Max in Tier)
0 - 1,000 $0.25 Up to $250
1,001 - 2,500 $0.20 Up to $500
2,501 - 10,000 $0.15 Up to $1,500
10,001 - 25,000 $0.12 Up to $3,000
25,001 - 50,000 $0.09 Up to $4,500
50,000+ Contact Us for a Custom Quote

What's Included in Every Standard Data Package

  • Company Name
  • Contact Name (where available)
  • Job Title (where available)
  • Full Business & Mailing Address
  • Business Phone Number
  • Industry Codes (Primary and Secondary SIC & NAICS Codes)
  • Sales Volume
  • Employee Count
  • Website (where available)
  • Years in Business
  • Location Type (HQ, Branch, Subsidiary)
  • Modeled Credit Rating
  • Public / Private Status
  • Latitude / Longitude
  • ...and more (Inquire)

Boost Your Data with Verified Email Leads

Enhance your list or opt for a complete 100% verified email list – all for just $0.10 per email!

Ideal for: Direct Mailing Email Campaigns Calling Market ResearchFree Sample & Report, Custom Lists, and Expert Support — All Included
Looking for more companies? See NAICS 541714 - Research and Development in Biotechnology (except Nanobiotechnology) - 16,888 companies, 209,763 emails.

NAICS Code 541714-21 Description (8-Digit)

Laboratories-Biochemical is a subdivision of the NAICS Code 541714 that involves the application of biological and chemical principles to develop new products and processes. This industry is focused on the research and development of biotechnology, excluding nanobiotechnology. Laboratories-Biochemical companies conduct experiments and tests to understand the chemical and biological properties of living organisms and their interactions with the environment. The results of these experiments are used to develop new products, such as pharmaceuticals, vaccines, and diagnostic tests, as well as to improve existing products and processes.

Parent Code - Official US Census

Official 6‑digit NAICS codes serve as the parent classification used for government registrations and documentation. The marketing-level 8‑digit codes act as child extensions of these official classifications, providing refined segmentation for more precise targeting and detailed niche insights. Related industries are listed under the parent code, offering a broader context of the industry environment. For further details on the official classification for this industry, please visit the U.S. Census Bureau NAICS Code 541714 page

Tools

Tools commonly used in the Laboratories-Biochemical industry for day-to-day tasks and operations.

  • Spectrophotometers
  • Microscopes
  • Centrifuges
  • Electrophoresis equipment
  • PCR machines
  • Liquid chromatography systems
  • Gas chromatography systems
  • Mass spectrometers
  • NMR spectrometers
  • Microplate readers
  • Incubators
  • Autoclaves
  • Pipettes
  • Balances
  • PH meters
  • Freezers
  • Refrigerators
  • Water purification systems
  • Chemical hoods

Industry Examples of Laboratories-Biochemical

Common products and services typical of NAICS Code 541714-21, illustrating the main business activities and contributions to the market.

  • Pharmaceutical research
  • Vaccine development
  • Diagnostic test development
  • Bioprocessing
  • Genetic engineering
  • Protein engineering
  • Enzyme development
  • Antibody production
  • Biosensor development
  • Biofuel research

History

A concise historical narrative of NAICS Code 541714-21 covering global milestones and recent developments within the United States.

  • The Laboratories-Biochemical industry has a long and rich history dating back to the early 19th century when the first biochemical laboratory was established in France. The industry has since grown to become a vital part of the global economy, with notable advancements such as the discovery of DNA in the 1950s and the development of recombinant DNA technology in the 1970s. In the United States, the industry has seen significant growth since the 1980s, with the establishment of numerous biotech companies and the development of new drugs and therapies. Notable examples include the development of the first genetically engineered drug, Humulin, in 1982 and the approval of the first gene therapy, Gendicine, in 2003. The industry continues to evolve and innovate, with ongoing research in areas such as gene editing, personalized medicine, and synthetic biology.